Tumour immunology: false hopes—new horizons?
- 1 June 1998
- journal article
- Published by Elsevier in Immunology Today
- Vol. 19 (6), 247-250
- https://doi.org/10.1016/s0167-5699(98)01265-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Serological analysis of human tumor antigens: molecular definition and implicationsMolecular Medicine Today, 1997
- Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factorsOncogene, 1997
- Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?Molecular Medicine Today, 1997
- The many roles of CD40 in cell-mediated inflammatory responsesImmunology Today, 1996
- A central role of CD40 ligand in the regulation of CD4+ T-cell responsesImmunology Today, 1996
- Response of B-cell lymphoma to a combination of bispecific antibodies and saporinLeukemia Research, 1996
- Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicityEuropean Journal of Immunology, 1996
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B CellsScience, 1994
- Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladderCancer Immunology, Immunotherapy, 1984